🔗 Share this article

An underground market for unlicensed slimming drugs is propelled by TikTok fitness influencers and vendors on communication apps, based on recent findings.

Experimental Drug Gaining Traction Via Social Media

The experimental drug, which remains in clinical trials, is being promoted by social media influencers for its alleged fat-burning properties. Viewers are encouraged to message these accounts privately for supplier links, while also receiving promotional offers.

Thriving Trade on Social Networks

Separately, a robust market exists on messaging services, where groups with thousands of participants share “before and after” images, injection guides and claims of next-day British shipping. Sellers market the substance there before redirecting customers to other platforms for purchases.

Understanding Retatrutide

This medication is an experimental injectable developed by US drugmaker Eli Lilly. The drug targets three gut hormones – GLP-1, GIP and pancreatic hormone. Early trials indicate it could help individuals reduce up to a quarter of their total weight. Referred to as the “triple G”, the drug is being promoted online as the successor to Ozempic.

Medical Experts Express Concerns

However, doctors and pharmacists have cautions that the sale of what is still an unlicensed medication in the United Kingdom is worrisome and could result in individuals injecting products of unknown origin.

Some professionals stated the demand for retatrutide could be connected to the increasing price of approved slimming treatments such as Mounjaro.

Legal Position and Enforcement

Marketing retatrutide on social media or Telegram is prohibited in the UK, as it is an unlicensed drug that must not be marketed or distributed for personal consumption under the British medical regulations.

Some influencers try to circumvent the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but advertising and supply can still breach medicines, advertising, and customer regulations, risking penalties, legal action or imprisonment.

Platform Reaction and Material Elimination

According to the social media company, the service has taken down violative content and prohibited related hashtags and query recommendations. The organization said it was dedicated to maintaining the service safe and allocating resources in strengthening compliance measures.

Digital Trading Operations

Investigations also found communities with up to nine thousand participants selling retatrutide using the platform's built-in discovery tool, which operates like a online catalog. Entering “retatrutide” instantly brings up channels with numerous of members, populated with images of weight loss, glowing reviews and step-by-step guides for preparing or injecting at home.

After minutes of joining one community, a vendor shared contact information, where most transactions take place. The vendor provided an guidebook and promised shipping within 48 hours. When questioned whether the product was genuine, one seller responded: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. None inquired about weight, health issues or past usage.

Item Details and Pricing

Inside these groups, posts display dark colored parcels with postal service stickers, claiming to contain new batches. One message read: “It took eight of us to load them this morning.”

Customers can select between powder vials, mixed at home with sterile water, or pre-filled injectors typically priced at £160 for 20 milligrams. When asked how much time a pen should be used, sellers give conflicting responses varying between a several days to “depends on your body”.

Service Oversight and Security Actions

A spokesperson for the messaging service stated it actively moderated dangerous material on its service including content that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Medical Expert Warnings

“People are administering substances they cannot confirm. Although the science behind this drug is sound, these digital versions may not include what they advertise,” said Jason Murphy, the director of pharmaceutical services at Chemist4U.

A medical professional of an online medical service linked the surge in interest to recent cost increases for authorized slimming drugs such as Mounjaro. “With prices rising, patients are using social media. But fake injections are extremely risky. You cannot know what’s inside or whether the conditions they were produced in was sterile,” she said.

Her team has previously encountered individuals injured by self-injection from unconfirmed suppliers. “We recognize the disappointment, but buying from messaging apps or WhatsApp is gambling with your health,” said the doctor. “These substances could be contaminated or improperly measured.”

Manufacturer Statement

A spokesperson from Eli Lilly said retatrutide was in third stage research studies and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Consequently at this time no one can market [it] for personal consumption,” they explained, adding that any product “falsely representing itself as a Lilly experimental substance not yet approved … may expose patients to potentially serious health risks”.